| 摘要 |
<p>The invention relates to the field of psychoneurology and, in particular, to agents for treating multiple sclerosis. Substances that exhibit high activity in the treatment of multiple sclerosis are proposed from the group consisting of 1,3-dialkyl-benzimidazole halogenide compounds of general formula (I), where R1, R2 = methyl (Met), ethyl (Et), propyl (Pro), and X- = F-, ?l-, ?r-, J-.</p> |
